Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F20%3A73603905" target="_blank" >RIV/61989592:15310/20:73603905 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://pubs.rsc.org/en/content/articlelanding/2020/AY/D0AY00299B#!divAbstract" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2020/AY/D0AY00299B#!divAbstract</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1039/d0ay00299b" target="_blank" >10.1039/d0ay00299b</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology

  • Popis výsledku v původním jazyce

    Carcinoma antigen 125 (CA 125) has been recognized as a clinical glycoprotein/biomarker for the early-stage detection of ovarian cancer. Therefore, the precise determination of CA 125 is essential for cancer diagnosis and control. In this study, a novel biosensor was designed for the detection of the CA 125 biomarker in human plasma samples. For this purpose, the anti-CA 125 antibody was immobilized on the surface of the matrix containing Ag-DPA-GQD (silver nanoparticles deposited on the d-penicillamine-functionalized graphene quantum dots) conductive nano-ink modified CysA-Au NPs. The surface morphology of the electrode was investigated via field emission scanning electron microscopy (FE-SEM) and energy dispersive spectroscopy (EDS). The mechanism of nano-ink formation was evaluated via transmission electron microscopy (TEM). Also, the formation of an antigen-antibody complex was monitored using the differential pulse voltammetry (DPV) technique. The engineered immunosensor exhibited good performance with high specificity and sensitivity for the detection of the CA 125 biomarker. Under optimal conditions, the linear range of 0.001-400 U mL(-1) and low limit of quantification (LLOQ) 0.001 U mL(-1) were obtained. Based on the results, it can be concluded that this immunosensor promisingly has the potential to be employed in the early detection of ovarian cancer in clinical studies.

  • Název v anglickém jazyce

    A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology

  • Popis výsledku anglicky

    Carcinoma antigen 125 (CA 125) has been recognized as a clinical glycoprotein/biomarker for the early-stage detection of ovarian cancer. Therefore, the precise determination of CA 125 is essential for cancer diagnosis and control. In this study, a novel biosensor was designed for the detection of the CA 125 biomarker in human plasma samples. For this purpose, the anti-CA 125 antibody was immobilized on the surface of the matrix containing Ag-DPA-GQD (silver nanoparticles deposited on the d-penicillamine-functionalized graphene quantum dots) conductive nano-ink modified CysA-Au NPs. The surface morphology of the electrode was investigated via field emission scanning electron microscopy (FE-SEM) and energy dispersive spectroscopy (EDS). The mechanism of nano-ink formation was evaluated via transmission electron microscopy (TEM). Also, the formation of an antigen-antibody complex was monitored using the differential pulse voltammetry (DPV) technique. The engineered immunosensor exhibited good performance with high specificity and sensitivity for the detection of the CA 125 biomarker. Under optimal conditions, the linear range of 0.001-400 U mL(-1) and low limit of quantification (LLOQ) 0.001 U mL(-1) were obtained. Based on the results, it can be concluded that this immunosensor promisingly has the potential to be employed in the early detection of ovarian cancer in clinical studies.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

    —

  • OECD FORD obor

    10406 - Analytical chemistry

Návaznosti výsledku

  • Projekt

    —

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2020

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Analytical Methods

  • ISSN

    1759-9660

  • e-ISSN

    —

  • Svazek periodika

    12

  • Číslo periodika v rámci svazku

    12

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    11

  • Strana od-do

    1639-1649

  • Kód UT WoS článku

    000528701700011

  • EID výsledku v databázi Scopus

    2-s2.0-85083279452